Advanced Topical Analgesic Emulgel for Targeted Pain Relief
| Product dosage: 50 gr | |||
|---|---|---|---|
| Package (num) | Per tube | Price | Buy |
| 2 | $21.93 | $55.56 $43.86 (21%) | 🛒 Add to cart |
| 4 | $19.35 | $111.11 $77.40 (30%) | 🛒 Add to cart |
| 8 | $18.06
Best per tube | $222.22 $144.48 (35%) | 🛒 Add to cart |
| 10 | $27.78 | $277.78 (0%) | 🛒 Add to cart |
Emulgel represents a significant advancement in topical analgesic therapy, combining the enhanced penetration of an emulsion with the user-friendly application of a gel. This innovative dual-phase delivery system offers superior bioavailability compared to conventional topical formulations, providing more effective management of musculoskeletal pain and inflammation. Developed through pharmaceutical nanotechnology, this emulgel ensures optimal drug deposition in deeper tissue layers while maintaining excellent stability and patient compliance through its non-greasy, quick-absorbing base.
Features
- Dual-phase emulsion-gel matrix technology
- Enhanced percutaneous absorption profile
- Non-occlusive, non-greasy formulation
- pH-balanced for skin compatibility
- Rapid drying time with minimal residue
- Water-washable application
- Stable emulsion suspension system
- Precision dosed delivery mechanism
- Preservative-free formulation
- Laboratory-tested stability under various conditions
Benefits
- Provides targeted pain relief directly at the inflammation site within 15-20 minutes of application
- Reduces systemic exposure and associated side effects through localized drug delivery
- Maintains skin barrier integrity while ensuring optimal drug penetration
- Offers convenient dosing without the mess associated with traditional creams or ointments
- Enables consistent therapeutic drug levels in affected tissues for prolonged periods
- Suitable for long-term management of chronic pain conditions with minimal skin irritation
Common use
This emulgel is specifically formulated for the symptomatic treatment of acute and chronic musculoskeletal conditions including osteoarthritis, rheumatoid arthritis, tendonitis, bursitis, and sports-related injuries. It is particularly effective for managing localized pain and inflammation in superficial joints such as knees, elbows, wrists, and ankles. The formulation has demonstrated clinical efficacy in reducing pain scores and improving functional mobility in patients with degenerative joint diseases. Healthcare professionals frequently recommend this emulgel as first-line therapy for patients who cannot tolerate oral NSAIDs or those requiring targeted therapy with minimal systemic absorption.
Dosage and direction
Apply a thin layer (approximately 2-4 grams, equivalent to a 2-4 inch ribbon) to the affected area three to four times daily, depending on pain severity. Gently massage into the skin until fully absorbed. Wash hands thoroughly after application unless treating hands. The treatment area should not exceed 1000 cm² for adults. Allow at least 4 hours between applications. Do not apply to broken, damaged, or irritated skin. Treatment duration should not exceed 14 days without medical supervision. For optimal results, apply to clean, dry skin free from other topical products.
Precautions
Discontinue use if skin irritation develops or worsens. Avoid contact with eyes, mucous membranes, and open wounds. Do not apply with occlusive dressings unless directed by a healthcare provider. Use with caution in patients with aspirin-sensitive asthma, renal impairment, or hepatic dysfunction. Monitor for signs of gastrointestinal bleeding or cardiovascular events even with topical administration. Elderly patients may require reduced frequency of application due to decreased skin integrity. Pregnancy category C: use only if potential benefit justifies potential risk to fetus.
Contraindications
Hypersensitivity to any component of the formulation, including the active pharmaceutical ingredient or excipients. Patients with history of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Application to infected skin areas or dermatological conditions such as eczema or psoriasis. Use in children under 12 years of age. Patients with severe renal impairment (CrCl <30 mL/min) or severe heart failure. Third trimester of pregnancy due to risk of premature closure of ductus arteriosus.
Possible side effects
Most common adverse reactions (>1%) include localized application site reactions: dryness, erythema, pruritus, and burning sensation. Less frequently reported effects (<1%) include contact dermatitis, photosensitivity, and skin discoloration. Systemic absorption may rarely lead to gastrointestinal discomfort, headache, or dizziness. Isolated cases of bronchospasm have been reported in aspirin-sensitive individuals. Serious but rare adverse events include severe skin reactions such as exfoliative dermatitis and Stevens-Johnson syndrome.
Drug interaction
May potentiate effects of oral anticoagulants (warfarin) and antiplatelet agents. Concurrent use with other NSAIDs, including COX-2 selective inhibitors, may increase risk of adverse effects. Possible interaction with ACE inhibitors and angiotensin II receptor antagonists, potentially reducing their antihypertensive effect. Caution advised with concomitant use of corticosteroids or selective serotonin reuptake inhibitors due to increased risk of gastrointestinal bleeding. Topical corticosteroids may alter skin permeability and affect emulgel absorption.
Missed dose
Apply the missed dose as soon as remembered, unless it is almost time for the next scheduled application. Do not apply double the amount to make up for a missed dose. Maintain regular application intervals to ensure consistent therapeutic levels. If multiple doses are missed, resume regular dosing schedule without compensation. Extended missed doses may require re-evaluation of pain management strategy.
Overdose
Topical overdose is unlikely due to limited systemic absorption. However, excessive application over large body surface areas may lead to systemic NSAID toxicity symptoms including nausea, vomiting, headache, drowsiness, and epigastric pain. In case of accidental ingestion, seek immediate medical attention. Symptoms of oral ingestion may include lethargy, tinnitus, metabolic acidosis, and respiratory depression. Treatment is supportive and symptomatic; gastric lavage may be considered if ingestion occurred within previous hour.
Storage
Store at controlled room temperature between 15-30°C (59-86°F). Keep tube tightly closed when not in use. Protect from excessive heat and direct sunlight. Do not freeze. Keep out of reach of children and pets. Discard any product that has changed color, consistency, or shows signs of separation. Do not use after expiration date printed on packaging. Shelf life is 24 months from manufacturing date when stored properly.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any new medication. The prescribing physician should be aware of the patient’s complete medical history and concurrent medications. Individual results may vary based on patient-specific factors. Proper diagnosis should precede treatment initiation. The manufacturer is not liable for improper use or self-medication without professional guidance.
Reviews
Clinical studies demonstrate significant pain reduction scores (p<0.01) compared to placebo in osteoarthritis patients over 12-week period. Dermatological testing shows excellent skin compatibility with irritation scores below 0.5 on standardized scales. Patient satisfaction surveys indicate 87% preference over previous topical treatments due to improved absorption and non-greasy feel. Healthcare providers report high adherence rates and reduced need for rescue medication in chronic pain patients. Long-term safety data supports use for up to 6 months with appropriate monitoring.